The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation
Ha Phan(Center for Promotion of Advancement of Society), Thera P. Links(University Medical Center Groningen), Bruce H. R. Wolffenbuttel(University of Groningen), John Th. M. Plukker(University Medical Center Groningen), Pieter L. Jager(Hamilton Health Sciences), Rudi Dierckx(University Medical Center Groningen), Jacqueline E. van der Wal(Umeå University), Wim J. Sluiter(University Medical Center Groningen)
Cited by 86
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795
Simple non-invasive assessment of advanced glycation endproduct accumulation
|Diabetologia|2004|758
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562